Amylyx Pharmaceuticals IncNASDAQ:AMLX
No Matches were found for
- LAST PRICE1.7150
- TODAY'S CHANGE (%)-0.0050 (-0.2907%)
- Bid / Lots1.7100/ 10
- Ask / Lots1.7200/ 125
- Open / Previous Close1.7300 / 1.7200
- Day Range
- 52 Week Range
- Volume25,913
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 18948 | 1.715 |
May 31, 2024
Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), from 11:01PM ET on Friday May 31, 2024 by Dow Jones
11:01PM ET on Friday May 31, 2024 by Dow Jones
May 14, 2024
DJ Amylyx Pharmaceuticals Is Maintained at Neutral by Mizuho, from 6:57AM ET on Tuesday May 14, 2024 by Dow Jones
6:57AM ET on Tuesday May 14, 2024 by Dow Jones
May 10, 2024
DJ Amylyx Pharmaceuticals Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 8:35AM ET on Friday May 10, 2024 by Dow Jones
8:35AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Press Release: Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results, from 7:01AM ET on Thursday May 09, 2024 by Dow Jones
7:01AM ET on Thursday May 09, 2024 by Dow JonesAmylyx Pharmaceuticals Reports First Quarter 2024 Financial Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 117.0M | -1.6x | --- |
Organogenesis Holdings Inc | 364.6M | 63.8x | --- |
Amarin Corporation PLC | 355.4M | -6.7x | --- |
Coherus BioSciences Inc | 208.8M | -2.4x | --- |
Sinovac Biotech Ltd | 639.9M | -6.0x | --- |
Invitae Corp | 229.2K | 0.0x | --- |
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $117.0M |
|---|---|
Revenue (TTM) | $398.0M |
Shares Outstanding | 68.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $6.40 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
